Fewer platelets could be used for some cancer and bone-marrow transplantation patients

Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.

Read the whole article on Physorg

More from Physorg